Ranibizumab cost effective for common cause of vision loss

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.667, 2012-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zoledronic acid cost effective in preventing AI-associated bone loss

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 564, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Ranibizumab

By Blick Stephanie K.A.   Keating Gillian M.   Wagstaff Antona J.  

Drugs, Vol. 67, Iss. 8, 2007-01 ,pp. : 1199-1206

Adis International

Access to resources Recommend Favorite

Effective, Low-Cost, Simple, Disposable Cooling Tool for Patient Comfort in Common Dermatologic Procedures

By Hexsel Doris M.   Dal Forno Taciana   Soirefmann Mariana   Porto Mancela D.   Hexsel Camile L.  

Dermatologic Surgery, Vol. 39, Iss. 9, 2013-09 ,pp. : 1402-1404

Elsevier

Access to resources Recommend Favorite

Common vision needed for HIV vaccines

By  

Inpharma, Vol. 1, Iss. 1396, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Cost effective treatment options for AS

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 537, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite